Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Incorporated (LGND) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
lgnd · stock forecast · 17 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 17 Wall Street analysts in the past 3 months
Buy
17 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$289
Consensus
$268
+12.6% upside
Low
$252
Median: $265 · Last Close: $237.75
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$267.75
12.6% upside
High Target
$289
21.6%
Low Target
$252
6.0%
Current Price
$237.75
as of today
Based on analyst price targets, the LGND stock price prediction for the next 12 months ranges from $252 to $289. The consensus LGND price forecast of $267.75 implies 12.6% upside from the current price of $237.75.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $243.55 | ↑ 2.44% |
1-day model range: $242.33–$244.76. Peak: $244.76 (+2.44%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $428 | +80.0% |
| 2028 | $633 | +166.4% |
| 2029 | $816 | +243.1% |
| 2030 | $957 | +302.4% |
| 2031 | — | +344.1% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · LGND · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-08 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-04-30 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-04-28 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-04-15 | Citigroup | Maintains | Buy→Buy |
| 2026-04-14 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-24 | Citigroup | Maintains | Buy→Buy |
| 2026-02-27 | Oppenheimer | Maintains | Outperform→Outperform |
| 2026-02-24 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-12-10 | RBC Capital | Maintains | Outperform→Outperform |
| 2025-12-10 | Stifel | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Ligand Pharmaceuticals Incorporated (LGND) stock. Of the recent 98 rating actions, 2 were upgrades and 8 were downgrades. 17 analysts currently cover LGND.
Analyst Recommendation Trends
LGND analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 5 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$285M
↓ 34.3% YoY
Revenue Next Year
$363M
↑ 27.3% YoY
EPS This Year
$9.06
EPS Next Year
$11.13
↑ 22.9% YoY
EPS ForecastReported vs Estimated
Analysts forecast LGND EPS of $9.06 for the current fiscal year, based on estimates from 6 analysts. The LGND revenue forecast is $285M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The LGND stock forecast is supported by two independent data sources: analyst consensus ratings from 17 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus LGND price target is $267.75 (+12.6% upside), with an analyst consensus of Buy.
The LGND short-term stock prediction for tomorrow is $243.55 (+2.44%). The LGND stock price prediction for 2027 estimates an average of $428. The LGND stock prediction for 2030 projects a range of $904–$1009.
Ligand Pharmaceuticals Incorporated trades on NASDAQ under the ticker LGND. The LGND stock outlook for 2027 is broadly positive, supported by a Buy consensus among 71% of covering analysts.
Frequently asked questions
LGND forecast · 8 questionsAccording to 17 Wall Street analysts, the average 12-month LGND price target is $267.75, with a high forecast of $289.00 and a low of $252.00. The median price target is shown in the chart above when available. This implies +12.6% potential upside from the current price of $237.75.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.